Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Transplant Recipient”

913 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 913 results

Large-scale testing (Phase 3)Ended earlyNCT04258423
What this trial is testing

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Who this might be right for
Kidney Failure
Indiana University 4
Early research (Phase 1)UnknownNCT03591302
What this trial is testing

Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

Who this might be right for
Immune Tolerance
Stephan Busque 25
Not applicableUnknownNCT02733510
What this trial is testing

The Impact of Early Protocol Biopsy in Kidney Transplant

Who this might be right for
Chronic Renal Failure
Samsung Medical Center 200
Not applicableWithdrawnNCT04122105
What this trial is testing

PDE5i Use in Renal Transplant Recipients

Who this might be right for
Renal Transplant Failure
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT04225923
What this trial is testing

Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Who this might be right for
Cytomegalovirus Disease
Nobelpharma 87
Not applicableStudy completedNCT06016283
What this trial is testing

Sex Impact on Long-term Outcomes of LDKT

Who this might be right for
Kidney Transplant Failure and RejectionGender
Erasmus Medical Center 1,276
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Large-scale testing (Phase 3)Ended earlyNCT00223041
What this trial is testing

Cranoc Lipid Study in Renal Transplantation

Who this might be right for
Renal Transplantation
University Hospital Schleswig-Holstein 200
Not applicableStudy completedNCT01277770
What this trial is testing

Studies of Kidney Transplant Outcome

Who this might be right for
Transplant Recipient (Kidney)Steroid-Free Maintenance ImmunosuppressionPost-Transplant Infections+1 more
University of Minnesota 7,500
Large-scale testing (Phase 3)Study completedNCT02005562
What this trial is testing

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 252
Large-scale testing (Phase 3)Study completedNCT01150097
What this trial is testing

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipient
Novartis Pharmaceuticals 284
Post-approval studies (Phase 4)Study completedNCT00113269
What this trial is testing

Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 501
Not applicableLooking for participantsNCT07370727
What this trial is testing

Velocity-Based Resistance Training in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant RecipientsMetabolic SyndromeCardiovascular Risk Factors
Fundación Universitaria del Area Andina 12
Post-approval studies (Phase 4)Study completedNCT00306397
What this trial is testing

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
University Hospital, Basel, Switzerland 100
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Post-approval studies (Phase 4)Study completedNCT04225988
What this trial is testing

Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Cedars-Sinai Medical Center 20
Not applicableStudy completedNCT02633826
What this trial is testing

Pre-formed Alloreactivity in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationAcute Graft Rejection
Martina Sester 190
Testing effectiveness (Phase 2)WithdrawnNCT03327064
What this trial is testing

A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin Cancer
University of Alabama at Birmingham
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Load More Results